BMO Capital Starts Silence Therapeutics (SLN) at Outperform, 'a key player to watch'
Tweet Send to a Friend
(Updated - January 31, 2024 3:46 AM EST)
BMO Capital analyst Kostas Biliouris initiates coverage on Silence Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst Kostas Biliouris initiates coverage on Silence Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
